We have previously reviewed the participation of TNFα on the progression and metastasis of different breast cancer subtypes and the antitumor immune response mounted by different therapies (107), and also the mechanisms by which TNFα generates resistance to immunotherapy, such as monoclonal antibodies against cancer cells or immune checkpoints, and adoptive cell therapy elsewhere (108). Here, TNF is linked to breast carcinoma.